Article
Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer.
Lung cancer (Amsterdam, Netherlands) - 1 Jul 2023
Alsaddah Saba, Papadakis Andreas I, Wong Nora, Palma Laura, Szlachtycz David, Cruz Marino Tania, Fiset Pierre-Olivier, Foulkes William D
Abstract excerpt
BACKGROUND: Somatic epidermal growth factor receptor (EGFR) pathogenic variants have been identified and are routinely tested in the molecular diagnosis of non-small cell lung cancer (NSCLC) as they represent a target for EGFR tyrosine kinase inhibitor (TKI) therapy. However, germline variants in EGFR are much less frequently reported. CASE PRESENTATION: Herein, we report the case of a 46-year-old woman diagnosed...
Topics
- Female
- Humans
- Adult
- Middle Aged
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Protein Kinase Inhibitors
- ErbB Receptors
- Adenocarcinoma of Lung
- Lung
- Mutation
